Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Americas | 6,666.0 | 6,321.0 | 6,306.0 | 5,951.0 | 5,718.0 | 5,437.0 | 5,222.0 | |
| EMEA | 3,552.0 | 3,129.0 | 2,968.0 | 2,946.0 | 2,752.0 | 2,697.0 | 2,774.0 | |
| APAC | 2,803.0 | 2,475.0 | 2,300.0 | 2,202.0 | 2,114.0 | 2,029.0 | 1,972.0 | |
| Total revenues | 12,784.0 | 11,673.0 | 11,362.0 | 11,099.0 | 10,584.0 | 10,163.0 | 9,968.0 | 10,719.0 |
| Revenue growth [+] | 9.5% | 2.7% | 2.4% | 4.9% | 4.1% | 2.0% | -7.0% | 13.9% |
| Americas | 5.5% | 0.2% | 6.0% | 4.1% | 5.2% | 4.1% | | |
| EMEA | 13.5% | 5.4% | 0.7% | 7.0% | 2.0% | -2.8% | | |
| APAC | 13.3% | 7.6% | 4.5% | 4.2% | 4.2% | 2.9% | | |
| Medication Delivery | 7.0% | -1.8% | | | | | | |
| Cost of goods sold | 7,679.0 | 7,086.0 | 6,601.0 | 6,340.0 | 6,110.0 | 6,047.0 | 5,822.0 | 6,138.0 |
| Gross profit | 5,105.0 | 4,587.0 | 4,761.0 | 4,759.0 | 4,474.0 | 4,116.0 | 4,146.0 | 4,581.0 |
| Gross margin | 39.9% | 39.3% | 41.9% | 42.9% | 42.3% | 40.5% | 41.6% | 42.7% |
| Selling, general and administrative | 2,867.0 | 2,469.0 | 2,535.0 | 2,620.0 | 2,627.0 | 2,725.0 | 3,094.0 | 3,315.0 |
| Research and development | 534.0 | 521.0 | 595.0 | 654.0 | 615.0 | 646.0 | 603.0 | 610.0 |
| Other operating expenses | | -17.0 | -141.0 | -99.0 | | | | |
| EBITDA [+] | 2,594.0 | 2,437.0 | 2,561.0 | 2,355.0 | 2,005.0 | 1,545.0 | 1,208.0 | 1,448.0 |
| EBITDA growth | 6.4% | -4.8% | 8.7% | 17.5% | 29.8% | 27.9% | -16.6% | 28.0% |
| EBITDA margin | 20.3% | 20.9% | 22.5% | 21.2% | 18.9% | 15.2% | 12.1% | 13.5% |
| Depreciation | 592.0 | 601.0 | 606.0 | 602.0 | 596.0 | 637.0 | 601.0 | 623.0 |
| EBITA | 2,002.0 | 1,836.0 | 1,955.0 | 1,753.0 | 1,409.0 | 908.0 | 607.0 | 825.0 |
| EBITA margin | 15.7% | 15.7% | 17.2% | 15.8% | 13.3% | 8.9% | 6.1% | 7.7% |
| Amortization of intangibles | 298.0 | 222.0 | 183.0 | 169.0 | 154.0 | 163.0 | 158.0 | 169.0 |
| EBIT [+] | 1,704.0 | 1,614.0 | 1,772.0 | 1,584.0 | 1,255.0 | 745.0 | 449.0 | 656.0 |
| EBIT growth | 5.6% | -8.9% | 11.9% | 26.2% | 68.5% | 65.9% | -31.6% | 32.3% |
| EBIT margin | 13.3% | 13.8% | 15.6% | 14.3% | 11.9% | 7.3% | 4.5% | 6.1% |
| Non-recurring items | -6.0 | -2.0 | | | -33.0 | | | |
| Interest expense, net [+] | -192.0 | -134.0 | -71.0 | -3.0 | -85.0 | 43.0 | 106.0 | 123.0 |
| Interest expense | 217.0 | 162.0 | 120.0 | 105.0 | -55.0 | 66.0 | 126.0 | 145.0 |
| Interest income | 192.0 | 134.0 | 71.0 | 3.0 | 30.0 | 23.0 | 20.0 | 22.0 |
| Other income (expense), net [+] | -208.0 | -296.0 | -753.0 | 135.0 | -273.0 | 4,252.0 | 85.0 | -43.0 |
| Other non-operating gains/losses | 3.0 | -1.0 | 7.0 | -11.0 | -7.0 | 31.0 | 32.0 | -49.0 |
| Other | 41.0 | 190.0 | 731.0 | 78.0 | -133.0 | 4,275.0 | -105.0 | -70.0 |
| Pre-tax income | 1,477.0 | 1,292.0 | 970.0 | 1,617.0 | 1,100.0 | 4,954.0 | 428.0 | 490.0 |
| Income taxes | 182.0 | 182.0 | -41.0 | 65.0 | 491.0 | -12.0 | 35.0 | 33.0 |
| Tax rate | 12.3% | 14.1% | | 4.0% | 44.6% | | 8.2% | 6.7% |
| Minority interest | 11.0 | 8.0 | 10.0 | | | | | |
| Earnings from continuing ops | 1,284.0 | 1,102.0 | 1,001.0 | 3,104.0 | 1,218.0 | 4,966.0 | 393.0 | 457.0 |
| Earnings from discontinued ops | | | | -6.0 | -7.0 | -1.0 | 575.0 | 2,040.0 |
| Net income | 1,284.0 | 1,102.0 | 1,001.0 | 3,098.0 | 1,211.0 | 4,965.0 | 968.0 | 2,497.0 |
| Net margin | 10.0% | 9.4% | 8.8% | 27.9% | 11.4% | 48.9% | 9.7% | 23.3% |
| |
| Basic EPS [+] | $2.56 | $2.17 | $1.97 | $5.81 | $2.24 | $9.10 | $0.72 | $0.84 |
| Growth | 18.1% | 10.1% | -66.2% | 159.1% | -75.3% | 1161.3% | -14.5% | 45.3% |
| Diluted EPS [+] | $2.53 | $2.13 | $1.93 | $5.68 | $2.19 | $9.01 | $0.72 | $0.84 |
| Growth | 18.6% | 10.5% | -66.1% | 159.0% | -75.6% | 1159.0% | -14.3% | 45.6% |
| |
| Dividends per share [+] | $1.09 | $0.96 | $0.85 | $0.73 | $0.61 | $0.51 | $1.27 | $2.05 |
| Growth | 13.6% | 12.4% | 16.4% | 19.7% | 19.6% | -59.8% | -38.0% | 6.8% |
| |
| Shares outstanding (basic) [+] | 502.0 | 509.0 | 509.0 | 534.0 | 543.0 | 546.0 | 545.0 | 542.0 |
| Growth | -1.4% | 0.0% | -4.7% | -1.7% | -0.5% | 0.2% | 0.6% | -0.2% |
| Shares outstanding (diluted) [+] | 508.0 | 517.0 | 519.0 | 546.0 | 555.0 | 551.0 | 549.0 | 547.0 |
| Growth | -1.7% | -0.4% | -4.9% | -1.6% | 0.7% | 0.4% | 0.4% | -0.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|